Key result
Global longitudinal strain was a significant independent predictor of all-cause mortality (HR 1.09) and cardiovascular mortality (HR 1.16) in patients with advanced chronic kidney disease, showing superior predictive power compared to ejection fraction.
Why the study?
Does echocardiographic global longitudinal strain (GLS) better predict all-cause and cardiovascular mortality compared to ejection fraction in patients with advanced chronic kidney disease?
Cohort (n=183)
No
Does echocardiographic global longitudinal strain (GLS) better predict all-cause and cardiovascular mortality compared to ejection fraction in patients with advanced chronic kidney disease?
GLS may enhance mortality prediction beyond EF in advanced CKD; hypothesis-generating and requires validation before guiding care.
BACKGROUND: Echocardiographic global longitudinal strain (GLS) is increasingly recognised as a more effective technique than conventional ejection fraction (EF) in detecting subtle changes in left ventricular (LV) function. This study investigated the prognostic value of GLS over EF in patients with advanced Chronic Kidney Disease (CKD). METHODS: The study included 183 patients (57% male, 63% on dialysis) with CKD stage 4, 5 and 5Dialysis (D). 112 (61%) of patients died in a follow up of 7.8 ± 4.4 years and 41% of deaths were due to cardiovascular (CV) disease. GLS was calculated using 2-dimensional speckle tracking and EF was measured using Simpson's biplane method. Cox proportional hazard models were used to assess the association of measures of LV function and all- cause and CV mortality. RESULTS: The mean GLS at baseline was -13.6 ± 4.3% and EF was 45 ± 11%. GLS was a significant predictor of all-cause [Hazard Ratio (HR) 1.09 95%; Confidence Interval (CI) 1.02-1.16; p = 0.01] and CV mortality (HR 1.16 95%; CI 1.04-1.30; p = 0.008) following adjustment for relevant clinical variables including LV mass index (LVMI) and EF. GLS also had greater predictive power for both all- cause and CV mortality compared to EF. Impaired GLS (>-16%) was associated with a 5.6-fold increased unadjusted risk of CV mortality in patients with preserved EF. CONCLUSIONS: In this cohort of patients with advanced CKD, GLS is a more sensitive predictor of overall and CV mortality compared to EF. Studies of larger populations in CKD are required to confirm that GLS provides additive prognostic value in patients with preserved EF.
No takes yet. Share an insight, caveat, or question.
Krishnasamy et al. (2015) conducted a cohort in Advanced Chronic Kidney Disease (n=183). Global Longitudinal Strain (GLS) vs. Ejection Fraction (EF) was evaluated on All-cause mortality (HR 1.09, 95% CI 1.02-1.16, p=0.01). Global longitudinal strain was a significant independent predictor of all-cause mortality (HR 1.09) and cardiovascular mortality (HR 1.16) in patients with advanced chronic kidney disease, showing superior predictive power compared to ejection fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: